Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jun 29;4(6):e728.
doi: 10.1371/journal.pntd.0000728.

Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs

Paul T Cantey  1 , Jonathan Rout, Grace Rao, John Williamson, LeAnne M Fox
Affiliations

Increasing compliance with mass drug administration programs for lymphatic filariasis in India through education and lymphedema management programs

Paul T Cantey et al. PLoS Negl Trop Dis. .

Abstract

Background: Nearly 45% of people living at risk for lymphatic filariasis (LF) worldwide live in India. India has faced challenges obtaining the needed levels of compliance with its mass drug administration (MDA) program to interrupt LF transmission, which utilizes diethylcarbamazine (DEC) or DEC plus albendazole. Previously identified predictors of and barriers to compliance with the MDA program were used to refine a pre-MDA educational campaign. The objectives of this study were to assess the impact of these refinements and of a lymphedema morbidity management program on MDA compliance.

Methods/principal findings: A randomized, 30-cluster survey was performed in each of 3 areas: the community-based pre-MDA education plus community-based lymphedema management education (Com-MDA+LM) area, the community-based pre-MDA education (Com-MDA) area, and the Indian standard pre-MDA education (MDA-only) area. Compliance with the MDA program was 90.2% in Com-MDA+LM, 75.0% in Com-MDA, and 52.9% in the MDA-only areas (p<0.0001). Identified barriers to adherence included: 1) fear of side effects and 2) lack of recognition of one's personal benefit from adherence. Multivariable predictors of adherence amenable to educational intervention were: 1) knowing about the MDA in advance of its occurrence, 2) knowing everyone is at risk for LF, 3) knowing that the MDA was for LF, and 4) knowing at least one component of the lymphedema management techniques taught in the lymphedema management program.

Conclusions/significance: This study confirmed previously identified predictors of and barriers to compliance with India's MDA program for LF. More importantly, it showed that targeting these predictors and barriers in a timely and clear pre-MDA educational campaign can increase compliance with MDA programs, and it demonstrated, for the first time, that lymphedema management programs may also increase compliance with MDA programs.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Comment in

References

    1. WHO. Global programme to eliminate lymphatic filariasis. Wkly Epidemiol Rec. 2008;83:333–341. - PubMed
    1. WHO. Global programme to eliminate lymphatic filariasis. Wkly Epidemiol Rec. 2007;82:361–380. - PubMed
    1. Seim AR, Dreyer G, Addiss DG. Controlling morbidity and interrupting transmission: twin pillars of lymphatic filariasis elimination. Rev Soc Bras Med Trop. 1999;32:325–328. - PubMed
    1. Ramaiah KD. Lymphatic filariasis elimination programme in India: progress and challenges. Trends Parasitol. 2009;25:7–8. - PubMed
    1. Nandha B, Sadanandane C, Jambulingam P, Das P. Delivery strategy of mass annual single dose DEC administration to eliminate lymphatic filariasis in the urban areas of Pondicherry, South India: 5 years of experience. Filaria J. 2007;6:7. - PMC - PubMed

Publication types

MeSH terms